Amendment to Employment Agreement between NeoStem, Inc. and Dr. Robin L. Smith (July 29, 2009)

Summary

This amendment extends Dr. Robin L. Smith’s employment as Chairman and CEO of NeoStem, Inc. from December 31, 2010 to December 31, 2011. It also provides for annual cash bonuses on October 1st of 2009, 2010, and 2011, with the 2009 bonus contingent on the company’s merger with China Biopharmaceuticals Holdings, Inc. All other terms of the original agreement remain unchanged.

EX-10.1 2 v156403_ex10-1.htm

EXHIBIT 10.1

July 29, 2009

Dr. Robin L. Smith

930 Fifth Avenue

Suite 8H

New York, NY 10021

Dear Robin:

This letter is being written to serve as an amendment to the employment agreement by and between you and NeoStem, Inc. (the “Company”) dated as of May 26, 2006 (as amended on each of January 26, 2007, September 27, 2007, January 9, 2008 and August 29, 2008) pursuant to which you serve as the Company’s Chairman of the Board and Chief Executive Officer (the “Agreement”). Except as set forth herein, the Agreement shall remain unchanged. Initially capitalized terms used herein but not defined herein shall have the meaning set forth in the Agreement.

1. Extension of Term.

The Term of the Agreement is hereby extended from December 31, 2010 to December 31, 2011.

2. Cash Bonus.

You shall be paid a cash bonus on October 1st of each of 2009, 2010 and 2011. For 2009, the bonus shall be payable subject to the Company’s consummation of its proposed merger with China Biopharmaceuticals Holdings, Inc. and shall be in the amount of $275,000 and for 2010 and 2011 such cash bonus shall be for comparable minimum amounts.

Very truly yours,


NeoStem, Inc.

By:
Name:	Richard Berman
Title:	Chair, Compensation Committee


Accepted and Agreed:


Robin Smith